Schroder Investment Management Group’s Nektar Therapeutics NKTR Stock Holding History

Schroder Investment Management Group’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-437	Closed	-$316K	–	1322
2018 Q2	$316K	Sell	437 -501	-53%	-$578K	﹤0.01%	1114
2018 Q1	$1.5M	Buy	938 +4	+0.4%	+$5.15K	﹤0.01%	892
2017 Q4	$837K	Buy	934 +445	+91%	+$263K	﹤0.01%	1013
2017 Q3	$174K	Hold	489	–	–	﹤0.01%	1210
2017 Q2	$142K	Hold	489	–	–	﹤0.01%	1183
2017 Q1	$171K	Hold	489	–	–	﹤0.01%	1123
2016 Q4	$90K	Hold	489	–	–	﹤0.01%	1067
2016 Q3	$126K	Hold	489	–	–	﹤0.01%	1056
2016 Q2	$104K	Hold	489	–	–	﹤0.01%	1066
2016 Q1	$100K	Hold	489	–	–	﹤0.01%	1055
2015 Q4	$124K	Hold	489	–	–	﹤0.01%	1060
2015 Q3	$80K	Hold	489	–	–	﹤0.01%	1069
2015 Q2	$91K	Hold	489	–	–	﹤0.01%	1084
2015 Q1	$81K	Hold	489	–	–	﹤0.01%	1123
2014 Q4	$114K	Sell	489 -1,163	-70%	-$249K	﹤0.01%	1156
2014 Q3	$299K	Buy	1,652 +1,163	+238%	+$223K	﹤0.01%	1140
2014 Q2	$94.1K	Hold	489	–	–	﹤0.01%	1197
2014 Q1	$89K	Hold	489	–	–	﹤0.01%	1235
2013 Q4	$83.3K	Hold	489	–	–	﹤0.01%	1309
2013 Q3	$76.7K	Buy	+489	New	+$90.4K	﹤0.01%	1310

Other funds holding NKTR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Schroder Investment Management Group's NKTR Position: Q3 2018 in Review

Schroder Investment Management Group sold out of Nektar Therapeutics (NKTR) in Q3 2018, closing a stake of 437 shares — an estimated $316K sold.

Schroder Investment Management Group first reported a position in NKTR in Q3 2013 and held it in 20 quarters. The position peaked at $1.5M in Q1 2018. 388 funds tracked by Wall St. Rank hold NKTR as of Q3 2018.

Schroder Investment Management Group reported no remaining Nektar Therapeutics position as of Q3 2018 after selling out during the quarter.
Schroder Investment Management Group sold 437 Nektar Therapeutics shares in Q3 2018, an estimated $316K.
Schroder Investment Management Group first reported a position in Nektar Therapeutics in Q3 2013 and held it in 20 quarters.
Schroder Investment Management Group's Nektar Therapeutics position peaked at $1.5M in Q1 2018.
388 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2018.

Based on Schroder Investment Management Group's 13F filing for Q3 2018, filed 13 Nov 2018.